Brind.

A company with a subsidiary in the Netherlands sold it to AVS Bio, using the proceeds to invest in an AI-based SaaS platform.

1 report, 1 independent Updated Aug 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Netherlands

How it developed

Newest first. Tap a step to see who reported it.

Jun 8News originated from MIaMI in the Netherlands, leading to an AAIC conference in Toronto, involving Broadway.Sub-event
Jun 8The divestiture timeline for the Dutch subsidiary of ImmunoPrecise Antibodies Ltd. has been extended beyond initial expectations.Sub-event
Aug 6Company sells Netherlands subsidiary to AVS Bio, proceeds fund AI SaaS investment.1 source
- Business Wire

Keep exploring

The entities involved

Netherlands
one of the four autonomous countries of the Kingdom of the Netherlands; with territories in the Caribbean
- The Kingdom of the Netherlands, comprising entities like Aruba, Curaçao, and Sint Maarten, is detailed, including the co-hosting of a climate conference in Colombia.Mon 16:13
- Aruba, Curaçao, Sint Maarten, and the Netherlands collaborated on digitizing historical meteorological archives.Mon 16:13

Coverage

Newest first; wire copies grouped

Aug 6Business WireImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation AUSTIN, Texas, August 06, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: